Literature DB >> 8607801

Autocrine-paracrine effects of overexpression of hepatocyte growth factor gene on growth of endothelial cells.

S Hayashi1, R Morishita, J Higaki, M Aoki, A Moriguchi, I Kida, S Yoshiki, K Matsumoto, T Nakamura, Y Kaneda, T Ogihara.   

Abstract

Although hepatocyte growth factor (HGF) is synthesized in vascular cells, it is not known whether locally synthesized HGF acts similarly to exogenously added HGF. Therefore, we transfected cultured cells with human HGF vector and examined the effects on growth of vascular cells. Endothelial cells (EC) transfected with HGF vector synthesized and secreted high levels of HGF, and also showed significantly higher number. Addition of conditioned medium from vascular smooth muscle cells (VSMC) or EC transfected with HGF vector to nontransfected EC resulted in a significant increase in cell number, which was abolished by anti-HGF antibody. Co-culture of HGF-transfected VSMC with EC showed that HGF released from VSMC or EC stimulated EC growth. These results demonstrate that endogenously produced HGF by transfection of human HGF vector can exert autocrine and paracrine stimulatory effects on EC growth, but not VSMC growth, suggesting the role of local HGF system in cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8607801     DOI: 10.1006/bbrc.1996.0440

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Gene transfer of human hepatocyte growth factor into rat skin wounds mediated by liposomes coated with the sendai virus (hemagglutinating virus of Japan).

Authors:  Kuniaki Nakanishi; Maki Uenoyama; Naruya Tomita; Ryuichi Morishita; Yasufumi Kaneda; Toshio Ogihara; Kunio Matsumoto; Toshikazu Nakamura; Akie Maruta; Shigeo Matsuyama; Toshiaki Kawai; Takashi Aurues; Takuya Hayashi; Tomosumi Ikeda
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

2.  Stem cell therapy independent of stemness.

Authors:  Techung Lee
Journal:  World J Stem Cells       Date:  2012-12-26       Impact factor: 5.326

Review 3.  mRNA-based therapeutics--developing a new class of drugs.

Authors:  Ugur Sahin; Katalin Karikó; Özlem Türeci
Journal:  Nat Rev Drug Discov       Date:  2014-09-19       Impact factor: 84.694

Review 4.  Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis.

Authors:  Roger Abounader; John Laterra
Journal:  Neuro Oncol       Date:  2005-10       Impact factor: 12.300

5.  Hepatocyte Growth Factor Improves the Therapeutic Efficacy of Human Bone Marrow Mesenchymal Stem Cells via RAD51.

Authors:  Eun Ju Lee; Injoo Hwang; Ji Yeon Lee; Jong Nam Park; Keun Cheon Kim; Gi-Hwan Kim; Chang-Mo Kang; Irene Kim; Seo-Yeon Lee; Hyo-Soo Kim
Journal:  Mol Ther       Date:  2017-12-19       Impact factor: 11.454

6.  TNF-alpha employs a protein-tyrosine phosphatase to inhibit activation of hepatocyte growth factor receptor and hepatocyte growth factor-induced endothelial cell proliferation.

Authors:  Masahiro Sugano; Yoshiko Iwasaki; Masako Abe; Toyoki Maeda; Keiko Tsuchida; Naoki Makino
Journal:  Mol Cell Biochem       Date:  2008-11-12       Impact factor: 3.396

7.  Hepatocyte growth factor mediates mesenchymal stem cell–induced recovery in multiple sclerosis models.

Authors:  Lianhua Bai; Donald P Lennon; Arnold I Caplan; Anne DeChant; Jordan Hecker; Janet Kranso; Anita Zaremba; Robert H Miller
Journal:  Nat Neurosci       Date:  2012-06       Impact factor: 24.884

Review 8.  Hepatocyte Growth Factor Isoforms in Tissue Repair, Cancer, and Fibrotic Remodeling.

Authors:  Ognoon Mungunsukh; Elizabeth A McCart; Regina M Day
Journal:  Biomedicines       Date:  2014-11-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.